NIDA is seeking applications for high-risk/high-impact innovative research relevant to NIDA research priorities in (1) basic and clinical neuroscience; (2) drug discovery for medications development; or (3) genetics research involving genetic model systems or human genetics.
Application Deadlines: May 29, 2013
NIDA has agreed to commit up to $3.5 million in fiscal year 2013 funds to support approximately six R01 awards and $500,000 to support approximately two to three R21 awards.
NIDA supports research on the biomedical and behavioral causes, consequences, prevention, and treatment of drug abuse and addiction. Learn how research is supported by reading the Introduction to Funding.
Although some international researchers receive NIDA support through a direct foreign grant, most international research is supported through a domestic grant with a foreign component, where a principal investigator from a U.S. institution works with a researcher from another country.
The National Institute on Drug Abuse (NIDA) intends to commit $4 million to fund 8 to 10 awards in fiscal year 2012 to support implementation science projects that will inform the President’s Emergency Program for AIDS Relief (PEPFAR) as it develops more efficient and cost-effective methods to deliver HIV prevention, treatment, and care for drug-using populations.
As part of its effort to encourage rigorous collaborative international research, the NIDA International Program has issued three Program Announcements soliciting proposals for International Research Collaboration on Drug Abuse and Addiction Research to support projects that:
Last year, NIDA funded four new projects through its Program Announcements (PA) for International Collaboration on Drug Abuse and Addiction Research. The PAs solicit applications involving research partnerships between NIDA grantees at U.S. institutions and their partners in other countries. Three R01 Research Grant Proposals and one R21 Exploratory/Development Research Grant were funded: